Litigation Details for Boehringer Ingelheim Pharmaceuticals Inc. v. Lupin Ltd. (D. Del. 2021)
✉ Email this page to a colleague
Boehringer Ingelheim Pharmaceuticals Inc. v. Lupin Ltd. (D. Del. 2021)
Docket | ⤷ Sign Up | Date Filed | 2021-04-13 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
Jury Demand | None | Referred To | |
Patents | 10,022,379; 10,258,637; 10,406,172; 8,551,957; 9,155,705; 9,415,016; 9,949,998 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Boehringer Ingelheim Pharmaceuticals Inc. v. Lupin Ltd.
Details for Boehringer Ingelheim Pharmaceuticals Inc. v. Lupin Ltd. (D. Del. 2021)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2021-04-13 | 4 | Patent/Trademark Report to Commissioner of Patents | ;9,155,705 B2 ;9,415,016 B2 ;9,949,998 B2 ;10,022,379 B2 ;10,258,637 B2 ;10,406,172 B2. (apk) (Entered… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,551,957 B2 ;… 13 April 2021 1:21-cv-00530 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |